A retrospective, longitudinal study to evaluate healing lower extremity wounds in patients with diabetes mellitus and ischemia using standard protocols of care and platelet-rich plasma gel in a Japanese wound care program

Ostomy Wound Management

Volumn 58, Issue 4, 2012, Pages 36-49

  Sakata, Junichi ^a   Sasaki, Shigeru ^b   Handa, Kazuyoshi ^c   Uchino, Takashi ^d   Sasaki, Tsukasa ^e   Higashita, Ryuji ^f   Tsuno, Norio ^g   Hiyoshi, Toru ^b   Imakado, Sumihisa ^h   Morimoto, Shuhei ⁱ   Rinoie, Chugo ^j,k   Saito, Natsuko ^j  

^a Asahikawa Medical College   (Japan)

^b Wound Care Center   (United States)

^c JCHO Sendai Hospital   (Japan)

^d Wound Care Center   (United States)

^e Tokatsu Clinic Hospital   (Japan)

^f Yokohama General Hospital   (Japan)

^g Tonan Hospital   (Japan)

^h Department of Dermatology ^*  (Japan)

ⁱ JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^j Methodist Hospital California   (United States)

^k Millennia Wound Management Inc   (United States)

more..

Author keywords

diabetic foot ulcer; ischemia; platelet rich plasma; retrospective study; wound healing; wounds

Indexed keywords

AGED; ARTICLE; CLINICAL PROTOCOL; DIABETES MELLITUS; FEMALE; GEL; HUMAN; ISCHEMIA; JAPAN; LEG; LONGITUDINAL STUDY; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; THROMBOCYTE RICH PLASMA; VASCULARIZATION; WOUND HEALING;

AGED; CLINICAL PROTOCOLS; DIABETES COMPLICATIONS; FEMALE; GELS; HUMANS; ISCHEMIA; JAPAN; LEG; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PLATELET-RICH PLASMA; RETROSPECTIVE STUDIES; WOUND HEALING;

EID: 84865283282     PISSN: 08895899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. International Diabetes Federation. The Global Burden. IDF Diabetes Atlas Fifth Edition. Available at: www.idf.org/diabetesatlas/5e/the-global-burden. Accessed January 19, 2012.
2. Diabetes Net. Diabetic Population in Japan Increase to be the 6th in the World. Office of Diabetes Net. Available at: www.dm-net.co.jp/calendar/ 2012/016536.php. Accessed Jan 6, 2012.
3. Trans-national Institute of Health and Nutrition. Outline for the Results of the National Health and Nutrition Survey Japan, 2007; Dec. 2008. Ministry of Health, Labour and Welfare. Available at: www.nih.go.jp/eiken/english/ research/pdf/nhns2007.pdf. Accessed January 27.2012.
4. Centers for Disease Control Diabetes data and trends. Available at: www. cdc.gov/diabetes/statistics/complications-national.htm Accessed January 23, 2012.
5. Kumada Y, Ooura T. February 10 as "Foot Care Day". Office of Diabetes Net. Available at: www.dm-net.co.jp/calendar/2012/016573.php. Accessed January 16, 2012.
6. Wu SC, Driver VR, Wrobel JS, Armstrong DG. Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manage. 2007;3(1):65-76. (Pubitemid 46860717)
7. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45(5 suppl):S1-66.
8. Yan BP, Moran D, Hynes BG, Kiernan TJ, Yu CM. Advances in endovascular treatment of critical limb ischemia. Circ J. 2011;75:756-765.
9. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, et al. Prevalence of lower-extremity disease in the US adult population 40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004;27(7):1591-1597. (Pubitemid 38857431)
10. Van Belle E, Nikol S, Norgren L, Baumgartner I, Driver V, Hiatt WR, Belch J. Insights on the role of diabetes and geographic variation in patients with critical limb ischaemia. Eur J Vasc Endovasc Surg. 2011;42(3):365-373.
11. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA, 2005;293:217-228. (Pubitemid 40095873)
12. Dang CN, Boulton AJ. Changing perspectives in diabetic foot ulcer management. Int J Low Extrem Wounds. 2003;2:4-12.
13. Sigala F, Kontis E, Hepp W, Filis K, Melissas J, Mirilas P. Long-term outcomes following 282 consecutive cases of infrapopliteal PTA and association of risk factors with primary patency and limb salvage. Vasc Endovasc Surg. 2012;46:123-130.
14. Furukawa M, Shibuya H, Sato S, Tachikawa Y, Sako H. Treatment of CLI: Oita Oka's Challenge to Limb Salvage by Team Medicine. J Jap Soc Limb Salvage Podiatr Med. 2011;3:43-46.
15. Suissa D, Danino A, Nikolis A. Negative-pressure therapy versus standard wound care: a meta-analysis of randomized trials. Plast Reconstr Surg. 2011;128(5):498e-503e.
16. Reese RJ. Autologous platelet rich plasma (PRP): what do we know? Important concepts relevant to hair restoration surgery. Hair Transplant Forum International. 2010;Jan/Feb:14-17.
17. Frykberg RG, Driver VR, Carman D, Lucero B, Borris-Hale C, Fylling CP, Rappl LM, Clausen PA. Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series. Ostomy Wound Manage. 2010;56(6):36-44.
18. Jacobson M, Fufa D, Abreu EL, Kevy S, Murray MM. Platelets, but not erythrocytes, significantly affect cytokine release and scaffold contraction in a provisional scaffold model. Wound Repair Regen. 2008;16(3):370-378. (Pubitemid 351661575)
19. Driver VR, Hanft J, Fylling CP, Beriou JM, AutoloGel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage. 2006;52(6):68-74.
20. de Leon JM, Driver VR, Fylling CP, Carter MJ, Anderson C, Wilson J, et al. The clinical relevance of treating chronic wounds with an enhanced nearphysiological concentration of platelet-rich plasma gel. Adv Skin Wound Care. 2011;24(8):357-368.
21. Carter MJ, Fylling CP, Li WW, de Leon J, Driver VR, Serena TE, Wilson J. Analysis of run-in and treatment data in a wound outcomes registry: clinical impact of topical platelet-rich plasma gel on healing trajectory. Int Wound J. 2011;8(6):638-650.
22. Carter MJ, Fylling CP, Parnell LKS. Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty. 2011;11:e38.
23. FDA 510(k) clearance, BK060007. AutoloGel System. Rockville, MD: Cytomedix, Inc; September 20, 2007.
24. Lazarus GS, Cooper DM, Knighton DR, Margolis DJ, Pecoraro RE, Rodeheaver G, Robson MC. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol. 1994;130(4):489-493. (Pubitemid 24123372)
25. Castronuovo JJ Jr, Adera HM, Smiell JM, Price RM. Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia. J Vasc Surg. 1997;26(4):629-637. (Pubitemid 27459609)
26. Yamada T, Ohta T, Ishibashi H, Sugimoto I, Iwata H, Takahashi M, Kawanishi J. Clinical reliability and utility of skin perfusion pressure measurement in ischemic limbs-comparison with other noninvasive diagnostic methods. J Vasc Surg. 2008;47(2):318-23. (Pubitemid 351172677)
27. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004;39(7):885-910. (Pubitemid 39328144)
28. Esato K. [Clinical diagnosis of arteriosclerosis obliterans]. Nihon Geka Gakkai Zasshi. 1996;97(7):498-503.
29. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care. 2003;26:1879-1882. (Pubitemid 36929137)
30. Carter MJ, Fife CE, Walker D, Thomson B. Estimating the applicability of wound care randomized controlled trials to general wound-care populations by estimating the percentage of individuals excluded from a typical wound-care population in such trials. Adv Skin Wound Care. 2009;22(7):316-324.
31. Chisci E, Perulli A, Iacoponi F, Setacci F, de Donato G, Palasciano G, Cappelli A, Setacci C. Benefit of revascularization to critical limb ischaemia patients evaluated by a patient-oriented scoring system. Eur J Vasc Endovasc Surg. 2012; Feb 17 [Epub ahead of print].
32. Utter GH, Maier RV, Rivara FP, Nathens AB. Outcomes after ruptured abdominal aortic aneurysms: the "halo effect" of trauma center designation. J Am Coll Surg. 2006;203(4):498-505. (Pubitemid 44416248)
33. Gershater MS, Londahl M, Nyberg P, Larsson J, Thorne J, Eneroth M, Apelqvist J. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia. 2009;52(3):398-407.
34. Alexandrescu VA, Hubermont G, Philips Y, Guillaumie B, Ngongang C, Vandenbossche P, Azdad K, Ledent G, Horion J. Selective primary angioplasty following an angiosome model of reperfusion in the treatment of Wagner 1-4 diabetic foot lesions: practice in a multidisciplinary diabetic limb service. J Endovasc Ther. 2008;15(5):580-593.
35. Chung J, Bartelson BB, Hiatt WR, Peyton BD, McLafferty RB, Hopley CW, Salter KD, Nehler MR. Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia. J Vasc Surg. 2006;43(6):1183-1190. (Pubitemid 43825661)
36. Warriner RA, Snyder RJ, Cardinal MH. Differentiating diabetic foot ulcers that are unlikely to heal by 12 weeks following achieving 50% percent area reduction at 4 weeks. Int Wound J. 2011;8:632-637.
37. Sen CK,Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, et al. Human Skin Wounds: A major and snowballing threat to public health and the economy. Wound Repair Regen. 2009;17(6):763-771.